Trademark: 97533860
Word
CAIDYA
Status
Registered
Status Code
700
Status Date
Tuesday, September 24, 2024
Serial Number
97533860
Registration Number
7517006
Registration Date
Tuesday, September 24, 2024
Mark Type
4
Filing Date
Wednesday, August 3, 2022
Published for Opposition
Tuesday, October 17, 2023

Trademark Owner History
Clinipace, Inc. - Original Registrant

Classifications
35 Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management
45 Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields
42 Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, in particular gastroenterology, nephrology, urology, and oncology; consulting services in the field of scientific research in the nature of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices; Software as a service (SaaS) services featuring software for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials; Contract research organization (CRO) services, namely, custom technical writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports; Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports for submission to regulatory authorities
The wording "CAIDYA" has no meaning in a foreign language.

Trademark Events
Aug 6, 2022
New Application Entered
Aug 25, 2022
New Application Office Supplied Data Entered
May 19, 2023
Assigned To Examiner
Jun 1, 2023
Non-Final Action Written
Jun 1, 2023
Non-Final Action E-Mailed
Jun 1, 2023
Notification Of Non-Final Action E-Mailed
Sep 1, 2023
Teas Response To Office Action Received
Sep 1, 2023
Correspondence Received In Law Office
Sep 1, 2023
Teas/Email Correspondence Entered
Sep 7, 2023
Examiners Amendment -Written
Sep 7, 2023
Examiners Amendment E-Mailed
Sep 7, 2023
Notification Of Examiners Amendment E-Mailed
Sep 7, 2023
Examiner's Amendment Entered
Sep 7, 2023
Approved For Pub - Principal Register
Sep 27, 2023
Notification Of Notice Of Publication E-Mailed
Oct 17, 2023
Published For Opposition
Oct 17, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 12, 2024
Use Amendment Filed
Dec 12, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 12, 2024
Teas Statement Of Use Received
Aug 1, 2024
Statement Of Use Processing Complete
Aug 1, 2024
Case Assigned To Intent To Use Paralegal
Aug 17, 2024
Allowed Principal Register - Sou Accepted
Aug 17, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 24, 2024
Registered-Principal Register
Sep 24, 2024
Notice Of Registration Confirmation Emailed

Trademark Alertz updated from USPTO on 2030-01-24